As pressure grows to deliver drugs to market faster and at a lower cost, life sciences companies are in a race to derive better insights from data and analytics. But, are they able to access the required breadth and depth of insights from their own data alone?
If drug development is going to catch up to the digital age, cross-industry data, advanced analytics, and artificial intelligence (AI) become a true necessity. With fit-for-purpose data sources at hand, life science companies can better analyze their own clinical trial data and real-world data to build predictive models in ways that traditionally have not been possible.
Acorn AI’s offering for operational analytics, Intelligent Trials, delivers insights to improve the speed and success of trials through better study design, enhanced country and site selection, enrollment predictions, and real-time study tracking against other similar industry trials.
Explore and download our featured eBooks to see how you can gain the insight needed to build your competitive advantage.
If you’re a large sponsor looking to gain the insight to lead, this eBook discusses how to accelerate and optimize outcomes to lead the way in trial innovation and success rates.
If you’re a mid-sized or emerging sponsor looking to gain the insight to succeed, this eBook discusses how to safeguard your trials in an increasingly complex industry.
If you’re a CRO looking to gain the insight to outperform, this eBook discusses how to leverage data and analytics to win more bids and stand out from the competition.
Explore Intelligent Trials Use Cases